Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
369-06-001.
Training and Validation of Magnetic Needle Models for Interventional Localization
Impact: Metallic instruments used in MR-guided interventions can cause distortions that obscure their location and introduce treatment or biopsy error. This research is aimed toward providing more accurate and precise position information of these metallic instruments.
|
||
|
369-06-002.
Enabling MR-Guidance of Magnetically-Actuated Robotic Catheter Interventions Using Interleaved Imaging and Actuation
Impact: MR-actuated robotic catheters and MR imaging each offer benefits in cardiovascular interventions. However, catheter actuation creates artifacts in MR images. This work enables MR guidance during robotic interventions by removing actuation artifacts while maintaining predictable catheter motion.
|
||
|
369-06-003.
MRI-Guided IPL Boost in SBRT: Impact on PSA Nadir and Kinetics
Impact: MRI-guided
IPL boosting in SBRT may reduce PSA nadir, improving biochemical control in
prostate cancer. This could refine clinical protocols, guide future trials, and
highlight MRI’s role in enhancing precision radiotherapy outcomes for patients.
|
||
|
369-06-004.
MRI-Measured Prostate Volume Change Dynamics in MR-guided Stereotactic Body Radiotherapy by ADT and Risk Stratification
Impact: MRI-measured prostate volume changes during MRgSBRT
inform adaptive radiotherapy planning. Stratification by ADT and risk level
enhances understanding of volume dynamics, potentially improving treatment
precision and patient outcomes in prostate cancer management.
|
||
|
369-06-005.
Quality and performance assessment framework for interventional MR-microwave applicators
Impact: This study presents a quality-control
workflow for assessing power delivery of medical microwave ablation systems, enabling the user to evaluate and optimize parameters such as cable-length, leading to safer and more predictable MR-guided microwave ablations.
|
||
|
369-06-006.
Bend and Press: RF Shielding of Braided Venous Stents at Different Configurations
Impact: The RF shielding of two
braided venous stents at 1.5T and 3T changes when the stents are bent or
compressed. Smaller shielding at 1.5T makes this field strength favorable for
post-implantation imaging to diagnose vein patencies.
|
||
|
369-06-007.
Out-of-bore Respiratory Tracking for MRI-guided Percutaneous Interventions using a Noise Navigator
Impact: Passive
thermal-noise navigation allows respiratory tracking for interventional guidance outside the bore. This offers a practical path to MR-guided abdominal
interventions with full operator access without requiring any additional hardware.
|
||
|
369-06-008.
Feasibility of MR guided lung biopsy at 0.55T using 3D stack-of-spirals UTE
Impact: Our study demonstrated that UTE imaging at 0.55T allowed needle
visualization in lung parenchyma, potentially positioning mid-field MRI as a
platform for both pulmonary imaging and interventions.
|
||
|
369-06-009.
TGRAPPA-Initialized Unrolled Network for Low-Latency Cine Reconstruction Developed for Interventional MRI
Impact: A TGRAPPA-initialized unrolled network with pretrained coil sensitivity estimation module achieves high-quality, low-latency cine reconstruction within 144 ms per frame. The approach removes dependence on ESPIRiT and supports robust real-time imaging for MRI-guided cardiovascular interventions across dynamically changing imaging planes.
|
||
|
369-06-010.
Feasibility of Using Ultrashort Echo Time (UTE) Sequences for MRI-Guided Biopsy in the Musculoskeletal System
Impact: This optimized ultrashort echo time (UTE) MRI sequence optimized for MRI-guided biopsy, enables precise, artifact-minimized needle localization and improved procedural accuracy, addressing a key unmet need for reliable MRI-based guidance in challenging musculoskeletal biopsy interventions.
|
||
|
369-06-011.
Targeting Tumor Heterogeneity in Soft-tissue Sarcoma by MR-guided Biopsies
Impact: Multi-regional, multiparametric MRI-informed in-bore biopsy of heterogeneous soft-tissue sarcoma was demonstrated, with low procedural times. This approach mitigates tumor under-grading and establishes a practical platform for phenotype-guided treatment adaptation and investigation of correlations between MRI parameters and histopathology.
|
||
|
369-06-012.
A Dual Input Synthetic Tumor Generation Pipeline for Liver Lung Shunt Fraction Estimation
Impact: A liver specific biophysical deep learning model for perfusion quantification
can be used to predict elevated Lung Shunt Fraction noninvasively for TARE.
|
||
|
369-06-013.
Safety and Efficacy Evaluation of Magnetic Resonance-Guided Focused Ultrasound for Blood-Brain Barrier Opening
Impact: MRgFUS has been shown to reversibly open the blood-brain barrier (BBB), with the potential to deliver therapeutic agents noninvasively to target brain regions in patients with Brain tumor, Alzheimer’s disease and other neurodegenerative conditions.
|
||
|
369-06-014.
Baseline Body Composition Metrics from MR-Guided Radiotherapy Predict Post-Treatment Quality-of-Life in Prostate Cancer
Impact: This study demonstrates that routine MR-guided radiotherapy imaging enables baseline body composition screening. Early identification of patients with adverse body composition profiles allows proactive supportive care, improving long-term QoL, functional independence, and survivorship outcomes after therapy.
|
||
|
369-06-015.
Safety and efficacy of MRI-fluoroscopic guided microwave ablation of small subdiaphragmatic and pericardial liver tumors
Impact: MR‑fluoroscopic guidance enables precise craniocaudal antenna placement avoiding transpleural approaches, offering excellent local control and a favorable safety profile for small subdiaphragmatic and pericardial liver tumors—supporting MRgMWA as a viable minimally invasive option in challenging locations.
|
||
|
369-06-016.
MR safety framework enabling "in-MRI' catheter trajectory planning & putaminal gene therapy with non MR-conditional equipment
Impact: Using MR unlabelled/ferromagnetic equipment is necessary to carry out life-changing procedures within
the MR suite, such as accurate intracranial delivery of gene-therapy drugs. With an appropriate framework, procedures to mitigate the
additional MR-related risks can be successfully developed and deployed.
|
© 2026 International Society for Magnetic Resonance in Medicine